The antiestrogen [2‐(4‐benzyl­phenoxy)­ethyl]­diethyl­ammonium chloride

The crystal structure of the title compound, C₁₉H₂₆NO⁺·Cl^? (common name: N,N‐diethyl‐2‐[(4‐phenyl­methyl)phenoxy]‐ethan­amine hydro­chloride), contains one mol­ecule in the asymmetric unit. The planes through the two phenyl rings are roughly perpendicular. Protonation occurs at the N atom, to which the Cl^? ion is linked via an N—H?Cl hydrogen bond. The mol­ecule adopts an eclipsed rather than extended conformation.     

Di­methyl (1‐methyl‐1,3‐benzimidazol‐5‐yl)­amino­methyl­ene­propane­dioate monohydrate

In the title compound, C₁₄H₁₅N₃O₄·H₂O, there is a strong conjugation push–pull effect across the central double bond, as reflected in the molecular dimensions and the planarity of the en­amino­ne portion of the mol­ecule. The mol­ecule has an intramolecular hydrogen bond between the NH and CO groups in the Z configuration, adopting the chelated form. The two π systems of the mol­ecule (1‐methyl­benz­imidazole and en­amino­ne) are deconjugated and tilted with respect to each other by 15.6 (2)°. The solvent water mol­ecule is hydrogen bonded to the N¹ atom of the 1‐methyl­benzimidazolyl group.     

(6R*,16R*)‐9,14‐Dihydro‐6‐methyl‐6,16‐methano‐6H,16H‐[2,4]benzothiazepino[3,4‐d][1,3,5]benzoxadiazocine hydrobromide dimethylformamide hemisolvate

The title compound, C₁₉H₁₉N₂OS⁺·Br^?·0.5C₃H₇NO, is an oxygen‐bridged phenyl­pyrimidine derivative in which the heterocyclic ring is protonated, the positive charge being dispersed over both of the N atoms. Both mol­ecules in the asymmetric unit exist in an identical conformation, which consists of a central planar portion with the two terminal phenyl rings protruding from the same side of the plane. One of the independent mol­ecules forms a strong hydrogen bond with the bromide anion, while the other is hydrogen bonded to the di­methyl­form­amide solvent mol­ecule.     

Ranitidine hydro­chloride,a polymorphic crystal form

In the title compound, di­methyl­({5‐[2‐(1‐methyl­amino‐2‐nitro­eth­enyl­amino)­ethyl­thio­methyl]‐2‐furyl}­methyl)­ammon­ium chloride, C₁₃H₂₃N₄O₃S⁺·­Cl^?, protonation occurs at the di­methyl­amino N atom. The ranitidine mol­ecule adopts an eclipsed conformation. Bond lengths indicate extensive electron delocalization in the N,N′‐di­methyl‐2‐nitro‐1,1‐ethenedi­amine system of the mol­ecule. The nitro and methyl­amino groups are trans across the side chain C=C double bond, while the ethyl­amino and nitro groups are cis. The Cl^? ions link mol­ecules through hydrogen bonds.     

Two rhod­amine derivatives: 9‐[2‐(ethoxycarbonyl)phenyl]‐3,6‐bis(ethyl­amino)‐2,7‐di­methyl­xanthyl­ium chloride monohydrate and 3,6‐di­amino‐9‐[2‐(methoxy­carbonyl)­phenyl]xanthyl­ium chloride trihydrate

The title compounds, C₂₈H₃₁N₂O₃⁺·Cl^?·H₂O (common name rhod­amine‐6g), (I), and C₂₁H₁₇N₂O₃⁺·Cl^?·3H₂O (common name rhod­amine‐123), (II), both have planar xanthene skeletons with a formal +1 charge on the amino N atoms delocalized through the π‐electron system so that the N—Csp² bond distances indicate significant double‐bond character. The substituted planar phenyl groups make angles of 63.29 (8) and 87.96 (11)° with the xanthene planes in (I) and (II), respectively. In both mol­ecules, the carbonyl bond vectors point toward the xanthene rings. The ethyl­amine groups in (I) are oriented similarly with their CH₂–CH₃ bond vectors pointing nearly perpendicular to the xanthene plane. The chloride ions and water mol­ecules are disordered in both structures. In (I), the chloride ion and water mol­ecule are disordered between two sites. One water and chloride alternately occupy the same site with occupancy factors of 0.5. The other 0.5‐chloride and 0.5‐water occupy two distinct positions separated by 0.747 (8) Å. In (II), the chloride ion is disordered between three sites and one of the waters is disordered about two other sites. Both crystal structures are stabilized by hydrogen bonds involving the chloride ions, amino groups and water mol­ecules, as well as by π–π stacking between xanthene planes.     

1,2,4,5‐Tetrakis(2‐vinyl­pyridyl)­benzene–di­chloro­methane (1/2)

The title compound, C₃₄H₂₆N₄·2CH₂Cl₂, lies about an inversion center. The solvent mol­ecules interact with the benzene mol­ecule both through C—H⃛N hydrogen bonding to span pyridine N atoms of adjacent vinyl groups, possibly stabilizing the rotational conformation observed, and through a π interaction between a dichloromethane Cl atom and a pyridyl ring C—C bond of a c‐glide‐related mol­ecule. The benzene mol­ecules form stacks along the a axis such that two of the four olefin groups are properly oriented for photoreactivity (2+2 cyclo­dimerization).     

Absolute configuration of (+)‐(S)‐2‐(5‐fluoro‐2‐methoxy‐1,4‐benzodioxan‐2‐yl)­imidazolinium bromide

The title compound, C₁₂H₁₄FN₂O₃⁺·Br^?, crystallizes in the non‐centrosymmetric P2₁2₁2₁ space group. The absolute configuration of the pharmacologically active mol­ecule could be resolved in the hydro­bromide salt, the structure of which is reported. The mol­ecule of the title compound has the S configuration. The molecular packing in the crystal is stabilized by weak N—H?Br [N?Br = 3.240 (4) and 3.302 (4) Å] hydrogen bonding.     

(8‐Dimethylamino‐1‐naphthyl)dimethylammonium 3‐carboxy‐1,4,5,‐6,7,7‐hexachlorobicyclo[2.2.1]hept‐5‐ene‐2‐carboxylate hydrate

The structure of the title compound, C₁₄H₁₉N₂⁺·C₉H₃Cl₆O₄^?·H₂O, consists of singly ionized 1,4,5,6,7,7‐hexachlorobicyclo[2.2.1]hept‐5‐ene‐2,3‐dicarboxylic acid anions and protonated 1,8‐bis(dimethylamino)naphthalene cations. In the (8‐dimethylamino‐1‐napthyl)dimethylammonium cat­ion, a strong disordered intramolecular hydrogen bond is formed with N?N = 2.589 (3) Å. The geometry and occupancy obtained in the final restrained refinement suggest that the disordered hydrogen bond may be asymmetric. Water mol­ecules link the anion dimers into infinite chains via hydrogen bonding.     

Tetrakis(μ‐benzothiazole‐2‐thiolato)‐1:2κ4N:S2;1:2κ4S2:N‐dichloro‐1κCl,2κCl‐dirhenium(III)(Re—Re) dichloromethane solvate: a bridged complex with a long Re—Re quadruple bond

The title compound, [Re₂(C₇H₄NS₂)₄Cl₂]·CH₂Cl₂, consists of dirhenium mol­ecules with bridging N,S‐benzo­thia­zole‐2‐thiol­ate ligands, axial Cl^? ligands and intramolecular hydrogen bonding. These mol­ecules adopt somewhat staggered conformations, with a long Re—Re quadruple bond distance of 2.2716 (3) Å.     

7,8‐Dihydr­oxy‐4‐propyl‐1,2,3,4,4a,5,6,10b‐octa­hydro­benzo[f]quinolinium bromide monohydrate,a dopamine agonist

In the crystal structure of the title dopamine­rgic compound, C₁₆H₂₄NO₂⁺·Br⁻·H₂O, protonation occurs at the piperidine N atom. The piperidine ring adopts a chair conformation and the cyclo­hexene ring adopts a half‐chair conformation; together with the planar benzene ring, this results in a relatively planar shape for the whole mol­ecule. Classical hydrogen bonds (N—H⋯Br, O—H⋯Br and O—H⋯O) produce an infinite three‐dimensional network. Hydrogen bonds between water ­mol­ecules and Br⁻ anions create centrosymmetric rings throughout the crystal structure. Structural comparison of the mol­ecule with the ergoline dopamine agonist pergolide shows that it is the hydrogen‐bond‐forming hydr­oxy or imino group that is necessary for dopamine­rgic activity, rather than the presence of a phenyl or a pyrrole ring per se.     

3,5‐Di­amino‐6‐(2‐fluoro­phenyl)‐1,2,4‐triazine–di­methyl­form­amide (1/1)

The title compound, C₉H₈FN₅·C₃H₇NO, contains two independent complexes in the asymmetric unit, each consisting of one 3,5‐di­amino‐6‐(2‐fluoro­phenyl)‐1,2,4‐triazine mol­ecule and one di­methyl­form­amide solvent mol­ecule. One triazine mol­ecule is disordered over two conformations within the crystal, the occupancies being 62 (1) and 38 (1)%. The phenyl ring of this mol­ecule resolves into two conformations rotated by almost 180° about the bridging bond between the two rings, while the triazine rings approximately superimpose on each other. The triazine mol­ecules of the asymmetric unit differ in the dihedral angles between their respective phenyl and triazine ring planes, these being 57.6 (2)° for the fully occupied, and 76.9 (6) and 106.8 (8)° for the partially occupied mol­ecules. An extensive network of hydrogen bonds maintains the crystal structure.     

Methyl 1‐(4‐chloro­benzyl)‐2‐(4‐methyl­piperazin‐1‐yl)‐1H‐benz­imidazole‐5‐carboxyl­ate hemihydrate

The title compound, C₂₁H₂₃ClN₄O₂·0.5H₂O, contains two independent mol­ecules in the asymmetric unit. In each mol­ecule the piperazine ring adopts a chair conformation; the deviations of the piperazine N atoms from the best plane through the remaining four C atoms are ?0.678 (3) and 0.662 (3) Å in mol­ecule A, and 0.687 (3) and ?0.700 (3) Å in mol­ecule B. The mol­ecules are linked by two hydrogen bonds of the O—H?N type involving the O atom of the water mol­ecule of crystallization.     

Strong hydrogen‐bonded amino acid dimers in l‐alanine alaninium nitrate

The title compound, C₃H₇NO₂·C₃H₈NO₂⁺·NO₃^?, contains l ‐alanine–alaninium dimers bonded via the carboxyl groups by a strong asymmetric hydrogen bond with an O?O distance of 2.4547 (19) Å. The neutral alanine mol­ecule exists as a zwitterion, where the carboxyl group is dissociated and the amino group is protonated. The alaninium cation has both groups in their acidic form. The alanine mol­ecule and the alaninium cation differ only slightly in their conformation, having an N—C_α—C=O torsion angle close to ?25°. The dimers and the nitrate anion are joined through a three‐dimensional hydrogen‐bond network, in which the full hydrogen‐bonding capabilities of the amino groups of the two alanine moieties are realised.     

2,3,4,5,6‐Penta­nitro­aniline 1,2‐dichloro­ethane disolvate: `push–pull' deformation of aromatic rings by intra­molecular charge transfer

The title compound, C₆H₂N₆O₁₀·2C₂H₄Cl₂, forms layered stacks of penta­nitro­aniline mol­ecules, which possess twofold symmetry. The voids between these stacks are occupied by dichloro­ethane mol­ecules, which reside near a 2/m symmetry element and display pseudo‐inversion symmetry. The C atoms in one of the two solvent mol­ecules are threefold disordered. In the penta­nitro­aniline mol­ecule, considerable distortion of the benzenoid ring, coupled with the short C—N(H₂) bond and out‐of‐plane NO₂ twistings, point to significant intra­molecular `push–pull' charge transfer at the amino‐ and nitro‐substituted (ortho and para) positions, as theoretically quantified by natural bond orbital analysis of the π‐electron density.     

Bis­[1‐(p‐chloro­phenyl)‐5‐iso­propyl­biguanide‐κ2N2,N4]­nickel(II) dichloride di­methyl­form­amide solvate

The asymmetric unit of the title compound, [Ni(C₁₁H₁₆ClN₅)₂]Cl₂·C₃H₇NO, contains one monomeric nickel(II) com­plex cation, two Cl⁻ anions and one di­methyl­form­amide sol­vent mol­ecule. The Ni atom is coordinated to each of two 1‐­(p‐chloro­phenyl)‐5‐iso­propyl­biguanide (proguanil) ligands via two N atoms. The complex exhibits a square‐planar coordination, with the Ni atom lying 0.021 (2) Å out of the basal plane. The crystal packing is characterized by several hydrogen bonds.     

Bis{1‐[N‐(2‐methoxy­phenyl)imino­methyl]naphthalen‐2(1H)‐onato‐κ3O,N,O′}zinc(II) ethanol solvate

In the crystal structure of the title compound, [Zn(C₁₈H₁₄NO₂)₂]·C₂H₆O, the Zn atom displays a highly distorted octa­hedral coordination involving the O and N atoms of two mol­ecules of the Schiff base 1‐[N‐(2‐methoxy­phenyl)imino­methyl]naphthalen‐2(1H)‐one, which acts as an O,N,O′‐tridentate ligand. The ethanol mol­ecule is bound to the methoxy group of one ligand mol­ecule via a hydrogen bond.     

Di­propyl 3,6‐di­phenyl‐1,2‐di­hydro‐1,2,4,5‐tetrazine‐1,2‐di­carboxyl­ate

The title compound, C₂₂H₂₄N₄O₄, was prepared from propyl chloro­formate and 3,6‐di­phenyl‐1,2‐di­hydro‐s‐tetrazine. This reaction yields the title compound rather than di­propyl 3,6‐di­phenyl‐1,4‐di­hydro‐s‐tetrazine‐1,4‐di­carboxyl­ate. The 2,3‐di­aza­buta­diene group in the central six‐membered ring is not planar; the C=N double‐bond length is 1.285 (2) Å, and the average N—N single‐bond length is 1.401 (3) Å, indicating a lack of conjugation. The ring has a twist conformation, in which adjacent N atoms lie 0.3268 (17) Å from the plane of the ring. The mol­ecule has twofold crystallographic symmetry.     

N,N,N′,N′‐Tetra­methyl­ethyl­enedi­ammonium dichloride

The structure of the title compound, C₆H₁₈N₂²⁺.2Cl^?, has been determined and has a centre of symmetry. The mol­ecule has strong intermolecular hydrogen bonding between each Cl^? and an N—H bond [Cl?N = 3.012 (3) Å].     

(Z)‐7‐Chloro‐3‐[(3‐chloro­phenyl)­methyl­idene]‐4‐p‐tosyl‐3,4‐di­hydro‐2H‐1,4‐benzoxazine

In the title compound, C₂₂H₁₇Cl₂NO₃S, the mol­ecule is a substituted 3,4‐di­hydro‐2H‐1,4‐benzoxazine compound which has three phenyl rings which are essentially planar. The 3,4‐di­hydro‐2H‐oxazine part of the mol­ecule is fused to the benzo ring and has a half‐boat conformation; the dihedral angle between the planar part of the oxazine ring and the benzo ring is 10.2 (2)°. The (3‐chloro­phenyl)­methyl­idene substituent has a Z configuration in relation to the ring N atom of the oxazine moiety. Interestingly, the p‐toluenesulfonyl (p‐tosyl) substituent on the ring N atom protrudes away from the 3‐­chloro­phenyl substituent thus avoiding any steric interaction.     

[1,3‐Bis(2‐ethoxy­phenyl)imidazolidin‐2‐yl­idene]bromo­(cyclo­octa‐1,5‐diene)­rhodium(I)

The title complex, [RhBr(C₈H₁₂)(C₁₉H₂₂N₂O₂)], has a distorted square‐planar geometry. There are two mol­ecules, A and B, in the asymmetric unit. The Rh—C bond distance between the N‐heterocyclic ligand and the metal atom is 2.039 (2) Å in mol­ecule A and 2.042 (2) Å in mol­ecule B. The angle between the carbene heterocycle and the coordination plane is 87.56 (12)° in mol­ecule A and 87.03 (11)° in mol­ecule B. It is shown that the average Rh—C(COD) (COD is cyclo­octa­diene) distance is linearly dependent on the Rh—C(imidazolidine) distance in this type of compound. This can be ascribed to the steric hindrance produced by the packing. The crystal structure contains intra­molecular C—H⋯O and inter­molecular C—H⋯Br inter­actions.